|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 18.84 USD | +8.96% |
|
+3.52% | +3.74% |
| 06-16 | Avalo Therapeutics Plans IND Application for AVTX-010 in H1 2027 | MT |
| 06-16 | Avalo Therapeutics Expands Pipeline with AVTX-010, A Long-Acting Next-Generation Anti-Il-1? Antibody | CI |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Neutral | Neutral |
| Resistance | 19.29 | 22.87 | 21.57 |
| Spread/Res. | -2.33% | -17.62% | -12.66% |
| Spread/Supp. | +16.58% | +47.88% | +102.80% |
| Support | 16.16 | 12.74 | 9.29 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- AVTX Stock
- Charts Avalo Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
